Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years

Jamie Lopez Bernal; Nick Andrews; Charlotte Gower; Julia Stowe; Elise Tessier; Ruth Simmons; Mary Ramsay

doi:10.1093/cid/ciab881

Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years

Jamie Lopez Bernal^*
, Nick Andrews
, Charlotte Gower
, Julia Stowe
, Elise Tessier
, Ruth Simmons
, Mary Ramsay

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

We estimated the risk of death from coronavirus disease 2019 in vaccinated compared with unvaccinated patients. The risk of death was reduced 44% after 1 dose of the Pfizer-BioNTech BNT162b2 vaccine, 55% after 1 dose of the Oxford-Astrazeneca ChAdOx1 vaccine, and 69% after 2 doses of the BNT162b2 vaccine. This is above the protection provided against infection.

Original language	English
Pages (from-to)	349-351
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	78
Issue number	2
DOIs	https://doi.org/10.1093/cid/ciab881
Publication status	Published - 15 Feb 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciab881

Cite this

@article{ae61ade9f2e44529beb4feb2ba2ffd8d,

title = "Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years",

abstract = "We estimated the risk of death from coronavirus disease 2019 in vaccinated compared with unvaccinated patients. The risk of death was reduced 44\% after 1 dose of the Pfizer-BioNTech BNT162b2 vaccine, 55\% after 1 dose of the Oxford-Astrazeneca ChAdOx1 vaccine, and 69\% after 2 doses of the BNT162b2 vaccine. This is above the protection provided against infection.",

author = "\{Lopez Bernal\}, Jamie and Nick Andrews and Charlotte Gower and Julia Stowe and Elise Tessier and Ruth Simmons and Mary Ramsay",

year = "2024",

month = feb,

day = "15",

doi = "10.1093/cid/ciab881",

language = "English",

volume = "78",

pages = "349--351",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years

AU - Lopez Bernal, Jamie

AU - Andrews, Nick

AU - Gower, Charlotte

AU - Stowe, Julia

AU - Tessier, Elise

AU - Simmons, Ruth

AU - Ramsay, Mary

PY - 2024/2/15

Y1 - 2024/2/15

N2 - We estimated the risk of death from coronavirus disease 2019 in vaccinated compared with unvaccinated patients. The risk of death was reduced 44% after 1 dose of the Pfizer-BioNTech BNT162b2 vaccine, 55% after 1 dose of the Oxford-Astrazeneca ChAdOx1 vaccine, and 69% after 2 doses of the BNT162b2 vaccine. This is above the protection provided against infection.

AB - We estimated the risk of death from coronavirus disease 2019 in vaccinated compared with unvaccinated patients. The risk of death was reduced 44% after 1 dose of the Pfizer-BioNTech BNT162b2 vaccine, 55% after 1 dose of the Oxford-Astrazeneca ChAdOx1 vaccine, and 69% after 2 doses of the BNT162b2 vaccine. This is above the protection provided against infection.

UR - https://www.scopus.com/pages/publications/85185391835

U2 - 10.1093/cid/ciab881

DO - 10.1093/cid/ciab881

M3 - Article

C2 - 37758203

AN - SCOPUS:85185391835

SN - 1058-4838

VL - 78

SP - 349

EP - 351

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 2

ER -

Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this